Press Release
Feds Move To Axe Key DEA Marijuana Rules Clearing the Way for MMJ's FDA Compliant HD and MS Trials
"Trump's Deregulatory Mandate Is Finally Driving DEA Marijuana Policy Reform," states Duane Boise, CEO of MMJ BioPharma Cultivation. Under President Trump's Executive Order 14192 ("Unleashing Prosperity Through Deregulation"), DOJ's notice eliminates several DEA proposals long cited as "in process". Read More
Press Release
HighLevel Announces Star Lineup of Keynotes and Expert Panels for LevelUp 2025
Google's Kapil Dabi and OpenAI's Zach Lawryk join Jesse Itzler, Kevin Harrington, Neil Patel and more, alongside new panels designed to deliver tactical insights for affiliates, agencies and SaaS operators. Read More
Press Release
Medical Care Technologies Inc. (OTC Pink:MDCE) Subsidiary Infinite Auctions Secures $2.54M Memorabilia Inventory, Reinforcing Growth and Supporting AI Healthcare Mission
With high-value assets including a LeBron James 2016 NBA Finals game worn jersey and rare Tom Brady 1/1 card, Infinite Auctions bolsters MDCE's balance sheet to accelerate development of its AI health platform. Read More
Press Release
MIXT IV Spa: Bringing Modern IV Therapy to Los Alamitos & Surrounding Cities
MIXT IV Spa, a Modern Health and Wellness Destination, is Excited to Announce Its Opening in Los Alamitos, Proudly Serving the Community and Nearby Cities Including Rossmoor, Seal Beach, Long Beach, Belmont Shore and Cypress Read More
Press Release
ARIA Cybersecurity Secures Midwest Manufacturer's Critical Systems with Managed AZT PROTECT(TM) Service Deployment
New Deployment Showcases ARIA Cybersecurity's Commitment to Safeguarding Mid-Sized Manufacturers with 24x7 Managed Service that Ensures Compliance and Protects Critical Operations Without Costly Upgrades Read More
Press Release
Imagene AI and Sheba Medical Center Launch a Precision Oncology Intelligence Alliance to Scale Personalized Cancer Care
Strategic collaboration will integrate Sheba's real-world data with Imagene AI's Cross Modality Intelligence Engine to enable multimodal research, predictive models, and faster translation to care "Partnering with an innovative leader like Imagene AI strengthens our mission to transform Sheba into an AI-driven hospital and a global model of healthcare innovation" Read More
Press Release
Protagonist Announces Icotrokinra Application for Approval in Plaque Psoriasis Submitted to the European Medicines Agency
Icotrokinra is a first-in-class investigational targeted oral peptide that selectively blocks the IL-23 receptor 1 Filing based on four Phase 3 studies that met all primary and co-primary endpoints. This unprecedented data package includes head-to-head superiority comparisons versus deucravacitinib, adolescent data, and evaluation of difficult to treat skin sites2,3,4,5,6 Submission underscores that icotrokinra has the potential to offer moderate-to-severe plaque psoriasis patients the combination of complete skin clearance and a favourable safety profile, relative to comparators, with the simplicity of a once-daily tablet. 2,3,4,5,6 Read More
Press Release
